458 related articles for article (PubMed ID: 33328530)
1. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
Linciano P; Citti C; Russo F; Tolomeo F; Laganà A; Capriotti AL; Luongo L; Iannotta M; Belardo C; Maione S; Forni F; Vandelli MA; Gigli G; Cannazza G
Sci Rep; 2020 Dec; 10(1):22019. PubMed ID: 33328530
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
Linciano P; Citti C; Luongo L; Belardo C; Maione S; Vandelli MA; Forni F; Gigli G; Laganà A; Montone CM; Cannazza G
J Nat Prod; 2020 Jan; 83(1):88-98. PubMed ID: 31891265
[TBL] [Abstract][Full Text] [Related]
3. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ
Citti C; Linciano P; Russo F; Luongo L; Iannotta M; Maione S; Laganà A; Capriotti AL; Forni F; Vandelli MA; Gigli G; Cannazza G
Sci Rep; 2019 Dec; 9(1):20335. PubMed ID: 31889124
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of Medical Cannabis.
Amin MR; Ali DW
Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
[TBL] [Abstract][Full Text] [Related]
5. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
6. Enantioseparation of chiral phytocannabinoids in medicinal cannabis.
Russo F; Tolomeo F; Angela Vandelli M; Biagini G; Laganà A; Laura Capriotti A; Cerrato A; Carbone L; Perrone E; Cavazzini A; Maiorano V; Gigli G; Cannazza G; Citti C
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Apr; 1221():123682. PubMed ID: 36965450
[TBL] [Abstract][Full Text] [Related]
7. Cannabimimetic activity (delta 1-THC cue) of cannabidiol monomethyl ether and two stereoisomeric hexahydrocannabinols in rats and pigeons.
Järbe TU; Hiltunen AJ; Lander N; Mechoulam R
Pharmacol Biochem Behav; 1986 Aug; 25(2):393-9. PubMed ID: 3020594
[TBL] [Abstract][Full Text] [Related]
8. Cis-Δ
Tolomeo F; Russo F; Kaczorova D; Vandelli MA; Biagini G; Laganà A; Capriotti AL; Paris R; Fulvio F; Carbone L; Perrone E; Gigli G; Cannazza G; Citti C
J Pharm Biomed Anal; 2022 Sep; 219():114958. PubMed ID: 35930832
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
10. Chemical transformation of cannabidiol into psychotropic cannabinoids under acidic reaction conditions: Identification of transformed products by GC-MS.
Jeong M; Lee S; Seo C; Kwon E; Rho S; Cho M; Kim MY; Lee W; Lee YS; Hong J
J Food Drug Anal; 2023 Mar; 31(1):165-176. PubMed ID: 37224558
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
El-Alfy AT; Ivey K; Robinson K; Ahmed S; Radwan M; Slade D; Khan I; ElSohly M; Ross S
Pharmacol Biochem Behav; 2010 Jun; 95(4):434-42. PubMed ID: 20332000
[TBL] [Abstract][Full Text] [Related]
12. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
Todd SM; Arnold JC
Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
14. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
15. ¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification.
Peschel W; Politi M
Talanta; 2015 Aug; 140():150-165. PubMed ID: 26048837
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
[TBL] [Abstract][Full Text] [Related]
17. Biosynthetic origins of unusual cannabimimetic phytocannabinoids in Cannabis sativa L: A review.
Welling MT; Deseo MA; Bacic A; Doblin MS
Phytochemistry; 2022 Sep; 201():113282. PubMed ID: 35718133
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effects of Cannabidiol but Not Δ
Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
[TBL] [Abstract][Full Text] [Related]
19.
Canseco-Alba A; Rodríguez-Manzo G
Rev Invest Clin; 2023; 75(3):105-128. PubMed ID: 37441766
[TBL] [Abstract][Full Text] [Related]
20. Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ
Piscitelli F; Pagano E; Lauritano A; Izzo AA; Di Marzo V
Anal Chem; 2017 Apr; 89(8):4749-4755. PubMed ID: 28343385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
